ArticleJournal of medicinal chemistryPublished
Discovery of MK-1468: A Potent, Kinome-Selective, Brain-Penetrant Amidoisoquinoline LRRK2 Inhibitor for the Potential Treatment of Parkinson's Disease
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Journal of medicinal chemistry
- Published
- Topic
- Disease research
- Subject terms
- Brain; Humans; Parkinson Disease; Ion Channels; Protein Kinase Inhibitors; Mutation; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2
- PubMed ID
- 37861679
- Added to directory
- Source checked